Literature DB >> 15581875

Integrin alpha4beta1 function is required for cell survival in developing retina.

Sergiu T Leu1, Susan A L Jacques, Kevin L Wingerd, Sherry T Hikita, Erin C Tolhurst, Jan L Pring, Derek Wiswell, Lisa Kinney, Nichol L Goodman, David Y Jackson, Dennis O Clegg.   

Abstract

In the retina, integrins in the beta1 family have been shown to be important in many phases of neuronal development, particularly neuroblast migration and axon outgrowth. However, the functions of specific integrin heterodimers are not well defined. In this study, we investigated the functions of beta1 integrins in developing chicken retina by expression of a dominant-negative beta1A construct using a replication-competent retrovirus. Inhibition of integrins using this approach resulted in alteration of cell morphology and increased apoptosis, but did not preclude migration and axon elongation. In an attempt to identify which specific beta1 heterodimer was important, expression and function of the alpha4beta1 heterodimer were also investigated. At early developmental stages, alpha4 protein and mRNA were detected in undifferentiated neuroblasts throughout the retina. At later stages, expression was confined to retinal ganglion cells (RGCs) and amacrine cells. A small molecule antagonist of alpha4 integrins was shown to inhibit neurite outgrowth on recombinant soluble vascular cell adhesion molecule-1 (VCAM-1), a known ligand of alpha4beta1. Introduction of alpha4 antagonist in vivo gave rise to increased apoptosis and led to a thinning of the retina and reduced numbers of retinal ganglion cells (RGCs). We conclude that the integrin alpha4beta1 is important for survival of developing retinal neurons, including RGCs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15581875     DOI: 10.1016/j.ydbio.2004.09.003

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  9 in total

1.  The integrin needle in the stromal haystack: emerging role in corneal physiology and pathology.

Authors:  Sunil K Parapuram; William Hodge
Journal:  J Cell Commun Signal       Date:  2014-03-07       Impact factor: 5.782

2.  Constitutive expression of the alpha4 integrin correlates with tumorigenicity and lymph node metastasis of the B16 murine melanoma.

Authors:  Robert B Rebhun; Hua Cheng; Jeffrey E Gershenwald; Dominic Fan; Isaiah J Fidler; Robert R Langley
Journal:  Neoplasia       Date:  2010-02       Impact factor: 5.715

3.  Targeting of integrin beta1 and kinesin 2alpha by microRNA 183.

Authors:  Guorong Li; Coralia Luna; Jianming Qiu; David L Epstein; Pedro Gonzalez
Journal:  J Biol Chem       Date:  2009-11-24       Impact factor: 5.157

Review 4.  The role of integrins in glaucoma.

Authors:  Mark S Filla; Jennifer A Faralli; Jennifer L Peotter; Donna M Peters
Journal:  Exp Eye Res       Date:  2016-05-13       Impact factor: 3.467

5.  Up-regulation of integrin-linked kinase in the streptozotocin-induced diabetic rat retina.

Authors:  Yang-Jun Li; Yan-Nian Hui; Feng Yan; Zhao-Jiang Du
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-07-26       Impact factor: 3.117

6.  αν and β1 Integrins mediate Aβ-induced neurotoxicity in hippocampal neurons via the FAK signaling pathway.

Authors:  Hai-Yan Han; Jin-Ping Zhang; Su-Qiong Ji; Qi-Ming Liang; Hui-Cong Kang; Rong-Hua Tang; Sui-Qiang Zhu; Zheng Xue
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

7.  Region- and Cell-Specific Expression of Transmembrane Collagens in Mouse Brain.

Authors:  Aboozar Monavarfeshani; Courtney N Knill; Ubadah Sabbagh; Jianmin Su; Michael A Fox
Journal:  Front Integr Neurosci       Date:  2017-08-30

Review 8.  The expression and function of midkine in the vertebrate retina.

Authors:  E Gramage; J Li; P Hitchcock
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

9.  An experimental study to evaluate safety/toxicity of intravitreal natalizumab.

Authors:  Rohan Chawla; Madhu Nath; Laxmi Moksha; Tapas C Nag; Thirumurthy Velpandian
Journal:  Indian J Ophthalmol       Date:  2018-10       Impact factor: 1.848

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.